Replies to post #677826 on NorthWest Biotherapeutics Inc (NWBO)

[iclight]

Certain optimization work will be required so that the Flaskworks system will produce DCVax-L products with characteristics equivalent to the products made by the current DCVax-L manufacturing processes. This will then need to be confirmed by comparability studies.

They literally PRed it.

You think they wouldn't mention they accomplished this if it had actually happened? Only in bizarro NWBO world where major milestones are not PRed but shiny objects like irrelevant PIP, 10 year old P1 combo trial results, and spoofing get all the headlines.